← Back to patent-cliff list
CAS 1012057-17-8
4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl acetate hydrochloride
Codes: NRC-2694-006
Application context (from source-drug indications)
转移性上皮癌NRC-2694
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| NRC-2694 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
6,7-dimethoxyquinazolin-4(3H)-one→6-hydroxy-7-methoxyquinazolin-4(3H)-one→7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate→4-chloro-7-methoxyquinazolin-6-yl acetate hydrochloride→3-ethynylaniline→4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl acetate hydrochloride→4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-ol→4-(3-chloropropyl)morpholine→N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine hydrochloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.